Of clinical significance, an immune response that induces the EMT-associated emergence of CSCs as CD8+T-cells can induce the dedifferentiation of breast cancer cells, resulting in the generation of CD44+/CD24− stem cell-like cells [84]. The gene discussed is CD44; the disease is breast carcinoma.